# ToRsemide for pOstpartum HYpertension

> **NCT02813551** · PHASE2 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 118 (actual)

## Conditions studied

- Preeclampsia

## Interventions

- **DRUG:** Torsemide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02813551
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2017-07-28
- **Final completion:** 2017-09-09
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2019-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02813551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02813551, "ToRsemide for pOstpartum HYpertension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02813551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*